145 related articles for article (PubMed ID: 24418324)
1. The International Diabetes Federation’s 2013 World Diabetes Congress, Melbourne, Australia.
J Diabetes; 2014 May; 6(3):197-201. PubMed ID: 24418324
[No Abstract] [Full Text] [Related]
2. Diabetes News.
Regier EE; Gao HX; Close KL
J Diabetes; 2015 Nov; 7(6):749-53. PubMed ID: 26223410
[No Abstract] [Full Text] [Related]
3. Treatment of glycemic control in diabetes in the CVOT era.
Einhorn D
J Diabetes; 2020 Jan; 12(1):4. PubMed ID: 31746129
[No Abstract] [Full Text] [Related]
4. Point: Intensive glycemic control and mortality in ACCORD--a chance finding?
Lachin JM
Diabetes Care; 2010 Dec; 33(12):2719-21. PubMed ID: 21115777
[No Abstract] [Full Text] [Related]
5. Counterpoint: Intensive glucose control and mortality in ACCORD--still looking for clues.
Riddle MC
Diabetes Care; 2010 Dec; 33(12):2722-4. PubMed ID: 21115778
[No Abstract] [Full Text] [Related]
6. Biotech on the rise: diabetes.
Leewe J
Biotechnol J; 2009 Feb; 4(2):172-3. PubMed ID: 19226551
[No Abstract] [Full Text] [Related]
7. Should A1C targets be individualized for all people with diabetes? Arguments for and against.
Teoh H; Home P; Leiter LA
Diabetes Care; 2011 May; 34 Suppl 2(Suppl 2):S191-6. PubMed ID: 21525454
[No Abstract] [Full Text] [Related]
8. The end point is just the beginning.
Muchmore D
J Diabetes Sci Technol; 2011 Sep; 5(5):1287-9. PubMed ID: 22027330
[TBL] [Abstract][Full Text] [Related]
9. The burden of post-prandial hyperglycemia and its implications.
Shah SN; Das AK
J Assoc Physicians India; 2001 Jan; 49 Spec No():1-2. PubMed ID: 11245155
[No Abstract] [Full Text] [Related]
10. [HbA1c 8.5% in elderly people with diabetes: is it good enough?].
Bottermann P
MMW Fortschr Med; 2009 Jun; 151(26-29):38-9. PubMed ID: 19739547
[No Abstract] [Full Text] [Related]
11. The Human Factor: The Cost of Switching from Analog to Human Insulin.
Tsai A
Diabetes Forecast; 2017 Mar; 70(2):44-47. PubMed ID: 29897684
[No Abstract] [Full Text] [Related]
12. [Inhaled insulin].
Uchigata Y
Nihon Rinsho; 2002 Sep; 60 Suppl 9():534-41. PubMed ID: 12387047
[No Abstract] [Full Text] [Related]
13. SARS-CoV-2 infection-related diabetes mellitus.
Beliard K; Wilkes M; Yau M; Aluf A; Rapaport R
J Diabetes; 2021 Jun; 13(6):523-524. PubMed ID: 33660918
[No Abstract] [Full Text] [Related]
14. Benefits of combination therapy of insulin and oral hypoglycemic agents.
Garber AJ
Arch Intern Med; 2003 Aug 11-25; 163(15):1781-2. PubMed ID: 12912710
[No Abstract] [Full Text] [Related]
15. Agents for the treatment of diabetes mellitus.
O'Mara NB
Semin Dial; 2010; 23(5):475-9. PubMed ID: 21069919
[No Abstract] [Full Text] [Related]
16. American Diabetes Association - 75th Scientific Sessions (June 5-9, 2015 - Boston, Massachusetts, USA).
Glessner M
Drugs Today (Barc); 2015 Jun; 51(6):383-6. PubMed ID: 26261852
[TBL] [Abstract][Full Text] [Related]
17. A New Algorithm Dedicated to Blood Glucose Monitoring in Insulin-Treated Elderly Dependent People With Diabetes.
Grino M; Loundou A; Boucekine M; Alitta Q; Oliver C
J Diabetes Sci Technol; 2019 Mar; 13(2):410-412. PubMed ID: 30537870
[No Abstract] [Full Text] [Related]
18. [Neuropathy in too rapid HbA1c decrease].
Sommer C
MMW Fortschr Med; 2015 Jun; 157(11):34. PubMed ID: 26049343
[No Abstract] [Full Text] [Related]
19. New Medications for the Treatment of Diabetes.
Garg SK; Brackett S; Reinicke T; Hirsch IB
Diabetes Technol Ther; 2020 Feb; 22(S1):S149-S173. PubMed ID: 32069157
[No Abstract] [Full Text] [Related]
20. Individualizing Targets for Glycemic Control.
Burson R; Moran KJ
Home Healthc Now; 2018; 36(3):190-191. PubMed ID: 29722710
[No Abstract] [Full Text] [Related]
[Next] [New Search]
